Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Thyrocare Technologies Ltd ( (IN:THYROCARE) ).
Thyrocare Technologies Limited has appointed senior diagnostics professional Rajdeep Panwar as its Chief Commercial Officer, effective January 5, 2026, following approval by the company’s Board of Directors based on the Nomination and Remuneration Committee’s recommendation. Panwar brings over 21 years of experience in leading diagnostic networks, laboratory operations and commercial functions at major healthcare organisations including Medanta Labs, Apollo Diagnostics and Dr. Lal PathLabs, and his expertise in P&L management, network expansion, digital diagnostics and accreditation is expected to strengthen Thyrocare’s senior management bench and support the expansion and scaling of its diagnostic operations across diverse markets.
More about Thyrocare Technologies Ltd
Thyrocare Technologies Limited operates in the healthcare diagnostics industry, providing pathology and diagnostic testing services across India, with a focus on building and managing large-scale laboratory networks and supporting both metro and non-metro markets.
Average Trading Volume: 96,904
Technical Sentiment Signal: Strong Buy
Current Market Cap: 73.07B INR
Learn more about THYROCARE stock on TipRanks’ Stock Analysis page.